HEMASURE INC
S-1/A, EX-27, 2000-05-31
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: HEMASURE INC, S-1/A, 2000-05-31
Next: CWMBS INC MORTGAGE PASS THRO CERT SERIES 1993-12, 424B5, 2000-05-31



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF HEMASURE INC. FOR THE THREE MONTHS ENDED MARCH 31,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                                               0000919745
<NAME>                                       Battle Fowler LLP
<MULTIPLIER>                                             1,000
<CURRENCY>                                        U.S. DOLLARS

<S>                                               <C>

<PERIOD-TYPE>                                            3-MOS
<FISCAL-YEAR-END>                                  DEC-31-2000
<PERIOD-START>                                     JAN-01-2000
<PERIOD-END>                                       MAR-31-2000
<EXCHANGE-RATE>                                              1
<CASH>                                                  27,865
<SECURITIES>                                                 0
<RECEIVABLES>                                            1,178
<ALLOWANCES>                                                26
<INVENTORY>                                              1,470
<CURRENT-ASSETS>                                        31,253
<PP&E>                                                   4,521
<DEPRECIATION>                                           2,463
<TOTAL-ASSETS>                                          33,361
<CURRENT-LIABILITIES>                                    9,209
<BONDS>                                                      0
<COMMON>                                                   196
                                        0
                                                  0
<OTHER-SE>                                              23,921
<TOTAL-LIABILITY-AND-EQUITY>                            33,361
<SALES>                                                  1,816
<TOTAL-REVENUES>                                         1,816
<CGS>                                                    2,184
<TOTAL-COSTS>                                            2,184
<OTHER-EXPENSES>                                         2,723
<LOSS-PROVISION>                                             0
<INTEREST-EXPENSE>                                        (374)
<INCOME-PRETAX>                                         (3,319)
<INCOME-TAX>                                                 0
<INCOME-CONTINUING>                                     (3,319)
<DISCONTINUED>                                               0
<EXTRAORDINARY>                                              0
<CHANGES>                                                    0
<NET-INCOME>                                            (3,319)
<EPS-BASIC>                                              (0.19)
<EPS-DILUTED>                                                0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission